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Abstract:
The p75 neurotrophin receptor (p75NTR) possesses the ability to promote cell
survival or apoptosis upon activation. The specific signaling cascades regulated
by p75NTR in neurodegenerative pathologies are poorly understood due to the
multifaceted nature of the receptor. Prior studies associate oxidative stress, a
cellular condition induced by an overwhelming presence of reactive oxygen
species, with promoting proteolysis and subsequent activation of p75NTR in
dopaminergic neurons. Dopaminergic neurons express p75NTR and are of interest
in neurodegenerative research. The degeneration of these neurons occur during
the progression of Parkinson’s Disease. Here, we optimized an in vivo and an in
vitro protocol for modeling Parkinson’s Disease. Another aspect of this research
was to optimize an automated method to measure the degeneration index (DI) of
neurons. Developing an optimized in vivo model of Parkinson’s Disease may
provide insight into the role of p75NTR regarding the survival and health of
dopaminergic neurons within substantia nigra and striatum regions of the brain.
Developing an optimized in vitro model of Parkinson’s Disease may allow for
investigation to the effects of p75NTR mediated signaling events associated with
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oxidative stress on cellular function. The DI is a calculation of neurite
degeneration, which allows for the quantification of neurodegenerative diseases.
An optimized method of analysis has provided a streamlined approach to
calculating the DI and neurite fragmentation in culture. Preliminary data suggests
that our optimized protocols serve as a successful model of Parkinson’s Disease
and thus allow further analysis into how p75NTR signaling cascades affect cellular
outcome in Parkinson’s Disease.
Keywords and phrases:
P75 neurotrophin receptor, Parkinson’s Disease, neurodegeneration, oxidative
stress, dopaminergic neurons, neurotrophins, co-receptors, optimized model,
degeneration index, ANDI
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Figure 1: The proteolysis of p75NTR in response to oxidative stress associated
with the application of 6-hydroxydopamine or rotenone
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Figure 1: The proteolysis of p75NTR in response to oxidative stress
associated with the application of 6-hydroxydopamine or rotenone. A) A
representative diagram of the proteolytic event experienced by p75NTR in distinct
stages. The full-length region of the protein is cleaved by an enzyme to release
the extracellular domain while a secondary enzymatic event serves as a final
cleavage event to liberate the intracellular domain. B) A representative western
blot of rotenone lysates probed for p75NTR. The resulting protein bands suggest
that rotenone induces the proteolysis of p75NTR at concentrations of both 1µM
and 10µM. The proteolysis event of p75NTR may be observed by matching the
protein bands to the specific molecular weight, as each fragment of p75NTR is
assigned specific molecular weight. C) An example of a rotenone treatment on
LUHMES cells. The image each represent a cultured dish and the subsequent
degeneration observed 18 hours after the treatment was performed. Each image
represents a treatment condition as described in the methods section. D) An
example of a 6-hydroxydopamine (6-OHDA) treatment on LUHMES cells. Each
image represents the effects seen after an 18-hour treatment condition of varied
concentrations of 6-OHDA as described in the methods section.
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Figure 2: Investigation of p75NTR co-receptors present in cultured cell and whole
brain lysates
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Figure 2: Investigation of p75NTR co-receptors present in cultured LUHMES
cell lysates and whole brain lysates. A) A representative western blot utilized
to investigate three types of lysates for the presence of the p75NTR co-receptor
TrkB. This analysis was conducted to analyze the presence of p75NTR coreceptors within a population of dopaminergic neurons. The HEK (human
embryonic kidney cells) were used as a negative control and the whole brain
lysate was used as the positive control. When probed for the presence of TrkB,
the cultured LUHMES cells did not express a protein band. This suggests that
TrkB is not present within the cultured dopaminergic regions, while it may be
present in various regions of the brain. B) A representative western blot utilized
to probe three lysate samples for the presence of p75NTR co-receptor sortilin. All
three populations investigated were found to express sortilin. This is an indication
that sortilin is present within dopaminergic neurons and may interact with p75NTR.
C) An immunostaining assay was performed on a population of cultured
LUHMES cells to investigate the presence of tyrosine hydroxylase and sortilin.
The blue (first) image represents the fluorescent DAPI labeling for the nuclei of
the cells. The red (second) image represents the fluorescent labeling for tyrosine
hydroxylase commonly found within the dopaminergic neurons in cells. The
green (third) image represents the fluorescent labeling for sortilin to further
investigate the areas of the cell that possess sortilin. The combination (fourth)
image represents the overlay of each stain to provide context of the interactions
between each of the components (nuclei, dopaminergic neurons, sortilin).

VII

Figure 3: The effects of p75NTR on dopaminergic neurons and striatal
neurodegeneration in a mouse model of Parkinson’s Disease
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Figure 3: Investigation of dopaminergic neurons in an in vivo model of
Parkinson’s Disease. A) Representative image of fluorescent tyrosine
hydroxylase (TH) staining and quantification of dopaminergic neurons within the
striatum. To investigate the efficacy of the stereotaxic surgeries, the regions of
interest must be isolated and analyzed to evaluate neurodegeneration. There
was a visible reduction of staining intensity indicating a loss of dopaminergic
neurons within the striatum after being exposed to a dosage of 6hydroxydopamine (6-OHDA). The quantification was performed to evaluate the
average brightness after a series of days after injection. This graphical
representation indicates that as more time passes, the less bright the staining.
This can be interpreted as the longer the 6-OHDA interacts with the
dopaminergic neurons, the more degeneration occurs resulting in less
healthy/intact neurons able to express TH. B) A representative graph depicting
the number of dopaminergic neurons within the region of the substantia nigra that
were observed after the surgical procedure introducing 6-OHDA into the brain. C)
A representative graph depicting the amount of dopaminergic neurons present
within the region of substantia nigra after a surgery utilizing rotenone. This
analysis was performed by staining the tissue with a TH primary antibody and
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subsequent reagents from a VectorElite staining kit. DAB substrate was applied
as a secondary condition to develop the intensity of the stained neurons.
Following the staining procedure, a stereology program was used to sample
regions of the substantia nigra tissue to analyze the number of stained neurons.
This analysis allowed for a comparison between the regions of the brain
ipsilateral and contralateral to the site of the 6-OHDA treatment. C) A
representative graph depicting the number of dopaminergic neurons present after
one week of being exposed to an injected dose of rotenone. This analysis was
performed utilizing methods described above in 3B. D) The tissue was stained
with a TH primary antibody and subsequent reagents from a VectorElite staining
kit. DAB substrate was applied as a secondary condition to develop the intensity
of the stained neurons. Representative image of the substantia nigra between
the uninjected region and the region injected with 6-OHDA. The image was taken
via confocal microscopy and there is a visible reduction in the number of stained
dopaminergic neurons, suggesting that the model was successful in inducing
Parkinson’s Disease. E) An immunostaining assay was performed in the same
manner as described above in 3D. Representative image of the substantia nigra
between the uninjected region and the region injected with rotenone. The image
was taken via confocal microscopy and suggests a successful model of
Parkinson’s Disease.

IX

Figure 4: Optimization of an automated neurite degeneration index (ANDI) from a
traditional model for calculating DI
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Figure 4: Optimization of an automated neurite degeneration index (ANDI)
from a traditional model for calculating DI. A) Representative images were
acquired from varied treatment conditions of SCG cultures. The treatment set in
this image is an example of a hydrogen peroxide treatment set. Because
hydrogen peroxide is known to induce neurite degeneration, it was utilized at
various concentrations to observe the effect on neuronal degeneration. This
image represents a treatment of 500µM hydrogen peroxide applied to a culture of
SCG sympathetic neuronal ganglia. This application was performed as a
condition for measuring the degeneration index (DI). The images were collected
through Nikon and confocal microscopy after subjection to immunostaining of TH,
DAPI, TUJ1, and fluorescent staining. The image sets were run through ImageJ
(an open-sourced free software) and were incubated in a primary antibody that
targeted a specific component. For example, if TUJ1 was being investigated, a
primary antibody was applied to probe for it and if TH was being investigated, a
different primary antibody was utilized that specifically targeted TH. A secondary
antibody of Alexa Fluorophore 488 was used to perform a fluorescent analysis
assay. The image on the left represents the degeneration observed from the
application of hydrogen peroxide while the image on the right represents the
DAPI labeling of the nuclei B) Representative images of a vehicle condition of
cultured SCG’s that were immunostained and analyzed through ImageJ. To
perform a comparative analysis, the vehicle set of cultured SCG ganglia were
subjected to a sham treatment of water. After the 18-hour treatment time, the
culture was immunostained similar to the process mentioned above in 4A. The
image on the left represents a phase contrast image of the in-tact neurites, the
middle image represents a TUJ1 staining on the SCG culture, the final image
represents the DAPI labeled nuclei of the cells. C) Previous experiments using
LUHMES cells have indicated that there is not a statistical difference in using the
automated method (ANDI) or a manual method of measuring the DI. A benefit of
using ANDI is a more streamlined method of investigation as the levels of
subjectivity are decreased in using an automated method. These images serve
as an investigation if ANDI would accurately measure DI of several diverse types
of cells. D) A graphical quantification of the staining in 4C. These images allowed
for the observation that ANDI accurately measures neurite degeneration as there
is no significant statistical difference between ANDI and a manual method. E)
Representative images to analyze if ANDI would be able to measure across
various staining types. The immunostaining assay was conducted for TUJ1 and
TH to observe the DI of each across a vehicle and treatment condition. This
analysis indicates that ANDI may be used across various cell types and
treatments to calculate the DI. F) To investigate the efficacy of ANDI in
measuring DI analysis through two methods of immunostaining, a graph was
constructed to plot the comparative resulting values.
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Introduction:
The p75 neurotrophin receptor:
The p75 neurotrophin receptor (p75NTR) is a transmembrane protein that is
known to regulate cellular responses to a variety of biological conditions. P75NTR
has been investigated as a diagnostic biomarker for neurodegenerative disease.
Research has revealed that the receptor possesses the ability to regulate cellular
function including programmed cell death, growth of axons, axonal degeneration,
myelination, and synaptic plasticity (Kraemer et al 2014). Although p75NTR has
been associated with regulating various cellular processes, there remains a poor
understanding in the underlying signaling mechanisms of the receptor. It has
been reported that the receptor is present within the layers of the neocortex as
well as various populations of adult neurogenesis stem cells (DeFreitas et al
2001). These neurogenesis cells are often observed in neurodegenerative
pathologies such as Alzheimer’s and Parkinson’s Disease. Research suggests
that p75NTR promotes both cell survival and apoptotic pathways. This curious
effect may be further explained as research groups have observed that within the
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promotion of nociceptive sensory neurons the activation of p75NTR promotes
survival, but the activation of the same receptor promotes apoptosis in
sympathetic and motor neurons (DeFreitas et al 2001). In discerning the
signaling mechanisms and functionality of p75NTR , there may be a breakthrough
in understanding the role of the receptor in various pathologies.
Role of p75NTR in development:
There are various stages of physical, cognitive, and social development
that are documented and serve as the basic definition of maturation within
organisms. Development is important as it allows for intricate biological systems
and defining characteristics to begin to emerge. The development of the brain
and nervous system is a complex event that occurs over time with observable
impact and influence of various genetic and environmental factors. During the
process of development, p75NTR has been observed at low levels of expression in
the nervous systems aside from hippocampal synapse modification and
regulation of neurogenesis (Meeker and Williams 2015). This receptor has been
found within both the central nervous system (CNS) and the peripheral nervous
system (PNS) with increased expression in the spinal cord, brainstem,
cerebellum, hippocampus, and basal forebrain (Meeker and Williams 2015). A
population of neurons within the basal forebrain, referred to as cholinergic
neurons, have been demonstrated to express p75NTR during all stages of
development. Cholinergic neurons are responsible for providing a primary source
of acetylcholine to the region of the cerebral cortex. This source of acetylcholine
aids in regulation of excitability in the cortex and hippocampus, thus allowing the
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body to execute complicated cognitive tasks (Franco et al 2021). The p75NTR has
been documented to play a role in pleiotropic effects throughout the
developmental and mature CNS (Tang et al 2020). This receptor may contribute
to the foundational process of development as it is found within target regions of
the brain and nervous system at varied levels of expression through the
developmental stages. These levels of expression indicate that p75NTR play hold
a role in preserving or promoting age related conditions, such as Parkinson’s
Disease.
P75NTR and signaling cascades:
The p75NTR has been investigated in regard to its affinity to promote
survival or mediate apoptotic pathways upon stimulated induced activation
(Pathak and Carter 2017). There have been numerous studies investigating the
cellular outcomes when the receptor is targeted with various conditions to
promote a proteolytic event. P75NTR possesses a cysteine-rich extracellular
domain that allows for ligand binding, a single-transmembrane domain, and an
intracellular death domain (Zhong et al 2021). Researchers have identified
p75NTR to play a role in mediating the growth, survival, apoptosis, and migration
of tumor cells in populations of cancer cells. P75NTR has been investigated to
promote cell survival in the nerve sheath tumors known as schwannoma and
within breast cancer cells, but receptor has also been observed to inhibit the
growth of prostate, gastric, and bladder tumor cells (Zhong et al 2021). Another
study implicated the receptor in having the ability to facilitate signaling cascades
to induce death in a population of superior cervical ganglia found in primary

4

trigeminal and hippocampus (Bhakar et al 2003). Additional areas found to be
affected by the autonomous apoptotic pathway include the Schwann,
oligodendrocyte, and neuroblastoma cells as well as glia and neurons of the
spinal cord and brain after a traumatic injury (Bhakar et al 2003). In a comparable
way to how there have been a multitude of instances where the apoptotic
pathway has resulted in neurodegeneration, there have also been studies that
have examined the role of p75NTR in promoting survival. These aforementioned
studies have resulted in a collective understanding that cell survival may be
promoted by an absence of tropomyosin-related kinase receptors (Trk)
interacting with the receptor (Massa et al 2006). A study investigating the
interaction between p75NTR and signaling partners (referred to as ligands) found
that the receptor may encourage survival by antagonizing apoptotic pathways
(Majdan et al 2001). Research has demonstrated that p75NTR possesses a wide
range of reactions in response to injury and signaling partners. The receptor may
provide a pivotal role in the cellular regulation depending upon the cell type,
signaling cascades, ligand presence, and interaction of various co-receptors.
Structure of p75NTR:
Understanding the structure of p75NTR is important to gain insight into the
overall function and interactions of the receptor. This receptor is classified as a
type one integral membrane protein with a helical structure (Mineev et al 2015).
P75NTR is a member of the tumor necrosis factor receptor superfamily and
possesses four cysteine rich domains (Baldwin and Shooter 1994). When the
receptor interacts with neurotrophins, the neurotrophins bind to the cysteine rich
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domains 2, 3, or 4 (which are coded in exon III). There are several major sections
of the receptor, the cysteine-rich domain of the extracellular domain, the
transmembrane domain, and the intracellular domain (Almeida and Duarte 2014).
Upon understanding the various regions of p75NTR, a greater understanding of
the interactions between the receptor and other biological compounds (ligands,
co-receptors, etc).
The proteolytic event of p75NTR:
The proteolysis of p75NTR occurs in two major cleavage events and results
in a downstream signaling event. To begin the cleavage of the p75NTR, the
receptor must be “activated” by an outside stimulus. Once activated, the
extracellular domain (ECD) is cut and shed from the full-length receptor by the
metalloprotease enzyme ADAM17. The alpha converting enzyme (TACE)
releases tumor necrosis factor (TNF) to cleave the cysteine rich region of the
ECD from the rest of the receptor. A second cleavage event is induced through
the enzyme gamma secretase to release the intracellular domain (ICD) (Ahmed
et al 2006). Each cleaved region of the p75NTR receptor has an associated
molecular weight, which allows for each region to be tracked and observed
through an assay of western blotting. It is known that a full length p75NTR is 75
kDa, the ECD is 55 kDa, the CTF is 25 kDa, and the ICD is 19 kDa. When
observing these fragments, a molecular ladder is utilized; the protein bands can
be isolated to a specific molecular weight when compared to this ladder. The ICD
region within the p75NTR is similar in structure and function to that of the ICD
region seen in other members of the TNFR. The ICD of the TNFR is known to
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mediate apoptosis within a cell, allowing this region of p75NTR to mediate
neurodegeneration. (Kraemer et al 2014). A difference between the ICD of
p75NTR and TNFR is the interactions of this region. The ICD of p75NTR does not
interact with other death domain proteins, which is a behavior unlike the ICD
region of other common members of the TNFR (Coulson et al 2000). In
understanding the general method of the proteolytic event of p75NTR, one can
investigate how the additional binding of neurotrophin ligands and co-receptors
impact the cleavage event and expression of the receptor.
Relationship between neurotrophins and p75NTR:
Neurotrophins are a family of proteins that are known to induce the
survival and development of cells and neurons. Because this family encourages
survival and growth, they are classified as growth factors. There are two main
classifications of neurotrophins, pro- and mature-. Proneurotrophins are
uncleaved biological peptides while mature neurotrophins are considered to be
the active form of the protein (Meeker and Williams 2014). The pro-neurotrophins
include pro-brain derived neurotrophin (pro BDNF), pro-nerve growth factor (pro
NGF), pro-neurotrophin-3 (pro NT3), and pro-neurotrophin-4 (pro NT4) (Volosin
et al 2008). The recognized mature neurotrophins are brain derived neurotrophic
factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT3), and
neurotrophin-4 (NT4). Each of the pro-neurotrophins binds with high affinity to the
co-receptor known as sortilin, (a major co-receptor of p75NTR). Each of the
mature neurotrophins bind with the same affinity to p75NTR but bind to Trk
receptors (a major co-receptor of p75NTR) with an ordered and selective
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specificity. The neurotrophin NGF selectively binds to the p75NTR co-receptor
TrkA, the neurotrophins BDNF and NT4 selectively bind to the co-receptor TrkB,
and the neurotrophin NT3 selectively binds to the co-receptor TrkC (Shamovsky
et al 1999). Additionally, research has demonstrated that p75NTR is fairly localized
within specific regions of the brain. The basal forebrain and striatal neurons are
two examples of these localized regions where there is a colocalization that
occurs between the receptors p75NTR and Trk (Friedman and Greene 1999). The
signaling cascade that results from the interaction between p75NTR,
neurotrophins, and co-receptors is still being investigated to better understand
the mechanisms of the receptor.
Relationship between co-receptors and p75NTR:
Co-receptors are a broad term for a cellular component that serves as a
bridge between a signaling molecule and a primary receptor. Co-receptors of
p75NTR are known to bind to the neurotrophins and induce a signaling cascade to
occur from the interaction. The main co-receptors of p75NTR are tropomyosinreceptor kinase (TrkA, TrkB, and TrkC), sortilin, and nogo receptors (Meeker and
Williams 2014). When mature neurotrophins bind to Trk receptors, there is an
activated pathway called the mitogen-activated protein kinase cascade that
results from the dimerization and activation of intrinsic tyrosine kinase activity
within the Trk receptors. The binding of TrkA and NGF results in the stimulation
of neurite growth and innervation (Marlin and Li 2015). Studies have shown that
p75NTR plays a significant role in the affinity of neurotrophins to bind with TrkA
which occurs as p75NTR is present with TrkA at the plasma membrane and
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modulates the endocytosis of the kinase (Perrone et al 2005). TrkB forms an
interaction bind with the neurotrophins BDNF and NT4. The result of this
interaction has been documented to promote neuronal protection and general
survival. A multi-step cleavage event occurring through the nuclear factor kappa
light chain reaction (NFkB) when p75NTR and TrkB interact with each other. NFkB
is a molecule known as an inducible transcription factor and this molecule has
been observed in regulating genes involved in promoting inflammatory responses
(Liu et al 2017). Additionally, the JNK pathway was activated by this interaction
and thus resulted in a proteolytic cleavage event of p75NTR (Sandhya et al 2013).
The interaction between the neurotrophin NT3 and co-receptor TrkC results in
neuronal survival and differentiation within peripheral tissue (Sinnappah-Kang et
al 2005). Sortilin is part of the vacuolar protein sorting 10 protein family and is
located within brain tissue. Sortilin has been observed to contribute towards the
inflammation and calcification of arterial walls, dysregulation of metabolism, and
vascular disorders. When sortilin and proneurotrophins interact and bind, there is
an activation of a death signaling pathway (Goettsch et al 2018). Nogo receptors
are known to function as myelin associated proteins that bind to the p75NTR to
suppress axonal growth (Meeker and Williams 2014). The relationship between
p75NTR and the various co-receptors are observed to result in survival or death
via apoptotic pathway.
Relationship between neurodegeneration and p75NTR:
Neurodegeneration is a disease state that is a typical application to many
conditions that involve the deterioration of neurons, axons, and dendrites. In an
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etymological sense, the term “neuro” refers to nerve cells while the term
“degeneration” refers to a process of losing structure and function. Examples of
neurodegeneration disorders include Alzheimer Disease, Parkinson’s Disease,
Huntington’s disease, and Amyotrophic Lateral Sclerosis (Przedborski et al
2003). In the context of Parkinson’s Disease, there is a chronic and progressive
disorder resulting in cognitive deficits and mental impairment from a loss of
neurons (Ding et al 2015). Neurodegeneration can be observed within nerve cells
and can induce a reduction of function and death in a previously healthy system.
Modern medicine has provided a method of alleviating the symptoms of
Parkinson’s Disease, but not a method of reversing neurodegeneration (which is
the basis of Parkinson’s) (Ding et al 2015).
Parkinson’s Disease:
Parkinson’s Disease is classified as a neurodegenerative disease and is
often referred to as an age-related disease. Parkinson’s Disease is characterized
by physical symptoms along with mental symptoms. Several of these symptoms
include tremors, rigidity, memory loss, disordered speech, cognitive impairment,
and motor dysfunction (Chen et al 2022). In cases of diagnosed Parkinson’s
Disease, there is a progression of symptoms associated with stages of
degeneration. As the neurodegeneration progresses, as do the observable
symptoms.
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Oxidative Stress:
Oxidative stress is a phenomenon where toxic molecules accumulate
within a cell thus weakening it by interfering with normal cellular function (Meeker
and Williams 2014). In oxidative stress, reactive oxygen species (ROS) are
produced as by-products from cellular aerobic respiration. The cell is
overwhelmed by the presence of the ROS as the antioxidant compounds are not
able to remove the free radical ROS’s (Noh and Ha 2011). Research has found
that oxidative stress contributes to mitochondrial dysfunction and disruption of
normal processes of the cell. Due to deviation from normal function, the cell is
more vulnerable to degeneration and death at this stage. Studies have indicated
that when experiencing oxidative stress, there is damage done to the DNA, RNA,
proteins, and lipids (Sundar et al 2022). Oxidative stress is an event that causes
the homeostasis of the cell to become unbalanced and thus results in stressful
conditions. The population of dopaminergic neurons are sensitive to oxidative
stress and experience damage and increased susceptibility to death when
oxidative stress in applied.
Dopaminergic neurons:
Dopaminergic neurons are a specific population of neurons located within
the nervous system that are responsible for transmitting dopamine across the
synaptic cleft. Dopamine is a neurotransmitter that acts as a chemical messenger
to send signals between nerve cells. Midbrain dopaminergic neurons are
localized to specific regions of the brain; these two of these regions include the
substantia nigra pars compacta and the ventral tegmental area (VTA). The
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presence of these dopaminergic neurons are important to note as these neurons
are often associated with the regulation of motor and cognitive function (Gale and
Li 2008). A hallmark of Parkinson’s Disease is a reduction of dopaminergic
neurons throughout the regions of the brain (Luo and Huang 2016). Although
dopaminergic neurons are localized within the substantia nigra pars compacta,
the neurons project into the anterior region of the brain known as the striatum.
The myelinated axons of the neurons are projected into a region known as the
dorsal striatum located within the subcortex basal ganglia (Heltberg et al 2022).
The dopaminergic neurons in the VTA are associated with the reward-motivation
centers of the brain. Patients who have been diagnosed with Parkinson’s
Disease have shown a correlation with increased depression and decreased
activity in the motivation-rewards center due to a loss of dopaminergic neurons in
the VTA.
Lewy bodies and neurodegeneration:
Lewy bodies are protein aggregates of alpha synuclein located in a
buildup of plaque within the neurons. When alpha synuclein is concentrated in a
specific area, neurodegeneration is commonly observed. Alpha synuclein is a
protein that is expressed in the brain and can be found specifically in the
neocortex, hippocampus, substantia nigra, and cerebellum (Emamzadeh 2016).
has many functions within the cell including vesicle transport, transcription
regulation, and protein folding. Accumulation of alpha synuclein is known to
promote the misfolding of the alpha form of proteins. When proteins are
subjected to misfolding, there are common issues often documented including
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aggregation, loss of function, and neurodegeneration (Timmer et al 2018). The
accumulation of the misfolded alpha synuclein forms beta pleated sheets
(referred to as amyloid beta plaque sheets). Lewy bodies are the name given to
the abnormal deposits of alpha synuclein within the brain. Lewy bodies are
associated with neuronal toxicity and result in a depletion of dopaminergic
neurons in neurodegenerative disorders such as Parkinson’s Disease (Kasen et
al 2022). In a diagnosis of Parkinson’s Disease, there is often a correlation to the
observably high presence of these Lewy bodies.
The substantia nigra pars compacta:
A reduction of dopaminergic neurons within the substantia nigra has been
associated with cognitive and motor impairment in Parkinson’s Disease (Timmer
et al 2018). The substantia nigra pars compacta is a region of ventral midbrain
that contains a large source of dopaminergic neurons, thus allowing this region to
play a critical role in regulating motor and cognitive function. These dopaminergic
neurons project into the striatum to form an interaction known as a nigrostriatal
pathway (Tritsch et al 2012). The disruption of this pathway is observed in
various neurological disorders as an interruption of this pathway results in the
depletion of dopamine thus resulting in a decrease of neuronal executive function
within the brain.
The striatum:
The striatum is a region of the subcortical basal ganglia that receives input
from dopaminergic neurons. A common side effect of Parkinson’s Disease is
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motor and cognitive impairment as motor dysfunction is often attributed to a loss
of dopaminergic neurons within the dorsal striatum. This region of the brain is the
main recipient of the dopaminergic innervation and thus requires a level of
healthy dopaminergic neurons to ensure the behavior of motor and cognitive
functions occurs normally (Zhai et al 2019).
Importance of the project:
Parkinson’s Disease is the second most diagnosed neurodegenerative
disease after Alzheimer’s. This disease impacts seven to ten million people
globally. This disorder stems from a loss of neurons and thus a decrease in
dopamine production (Kraemer et al 2021). Parkinson’s Disease is associated
with neurodegeneration and thus is not reversible as this is an event that is not
able to be therapeutically targeted. Symptoms of Parkinson’s Disease are often
associated with cognitive and motor deficiencies such as trembling, memory loss,
and confusion (Meeker and Williams 2015). If the receptor (p75NTR) is able to
serve as a diagnostic biomarker, it may aid in therapeutic treatment of target
neurodegenerative diseases such as Parkinson’s Disease.
In vitro experimental design for optimizing protocols:
To investigate the role of p75NTR on neurodegeneration associated with
Parkinson’s Disease, in vivo and in vitro experimental models can be utilized. In
vitro methods of experimental models include utilizing immortalized embryonic
cell lines to observe the signaling cascades and mechanism of the p75NTR in
response to various stimuli and interactions. The Lund human mesencephalic
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cell line (LUHMES) is an immortalized line of embryonic cells. LUMES cells have
status of proliferating cells due to the expression of the tetracycline-regulatable
(Tet-off) myc transgenes. This type of cell allows for culturing and observing a
differentiation process as the cells grow into postmitotic neuronal cells. The cells
can be introduced to tetracycline, glial cell-derived neurotrophic factor, and
dibutryl cAMP to induce the differentiation stage (Edwards and Bloom 2019).
Performing assays such as cell treatments and western blots allow for the
cultured neurons to be further investigated and exposed to various conditions in
establishing an experimental model of Parkinson’s Disease (Zhang et al 2014).
When cells are allowed to differentiate and have a treatment of a chemical such
as 6-hydroxydopamine (6-OHDA) or rotenone applied to them, a comparative
model between cultured neurons and the neurons within a patient with a
neurodegenerative disorder is observable. By applying neurotoxins and
analyzing the cleavage events of p75NTR, one can replicate the conditions of
Parkinson’s Disease that is often observed in human patients. Another line of
cells utilized for Parkinson’s research is the neuroblastoma (SH-SY5Y line) This
line was established from immortalized bone marrow. These cells are utilized to
mimic the effects of Parkinson’s Disease in a drug-based approach. When a
neurotoxin (such as 6-hydroxydopamine) was introduced into the cell culture, it
was observed that the neurotoxin was transported via catecholaminergic neurons
via dopamine transporters. An accumulation of neurotoxins within the cell triggers
an event of oxidative stress. From this event, there was an observed production
of ROS and catecholamine quinones and thus the process in tandem resulted in
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neurodegeneration. Another example of a neurotoxin used to model Parkinson’s
Disease is the pesticide rotenone. This neurotoxin promotes formation of Lewy
Bodies and inhibits mitochondrial complex I via induced ROS production. The
mechanism of this neurotoxin is to enter the cell independent of transporters and
disrupt cell proliferation by inhibiting the mitochondrial respiratory chain complex I
(Xicoy et al 2017). Researchers utilize immortalized cell lines to perform assays
to provide increased confidence and validity to the study of Parkinson’s Disease.
Investigators are able to draw conclusions from elucidating signaling cascades
and observing biological functions that occur when a neurotoxin is introduced to
a culture. It is important to test the results of in vitro methods that are obtained
against the results of in vivo experimentation.
In vivo experimental design for optimizing protocols:
Another method of experimentation includes in vivo analysis. This method
is commonly carried out through use of a mouse model as there is great genomic
similarity between mice and humans. Along with this point, mice are easy to care
for and have an expedited breeding cycle making the choice for these animals as
experimental subjects a cost and time effective choice. There are many
similarities between a mouse model and a human model of Parkinson’s Disease
including the observable symptoms and morphological characteristics. To
investigate a model of Parkinson’s Disease, a comparative analysis may be
drawn between specific genotypes of mice when a neurotoxin in introduced to a
specific region of the brain. Mice studies may result in a greater understanding
and transference into human studies. Mice in these studies were given a dosage
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of a neurotoxic drug and are left for a specific time course before further tissue
analysis was conducted. During this time, the mice were monitored exhibiting any
symptoms of Parkinson’s Disease including turning, shivering, or tremoring. After
allowing the neurotoxic drug to interact naturally within the brain and nervous
system of the mouse, the mouse was anesthetized and euthanized prior brain
collection. The brain was cryopreserved to prevent tissue damage, and from this
point various assays may be performed to investigate the effects of Parkinson’s
Disease (Rocha et al 2022). Analytical assays commonly associated with this
form of experimental design include tissue immunostaining, tissue extraction,
quantification of neurons, and statistical analysis to observe the effect of a
neurotoxic drug within the in vivo model. When performing assays, it is important
to analyze a variety of treatment conditions and update protocols to ensure that
the proper methodology is carried out. Our lab sought to optimize a protocol of
mimicking Parkinson’s Disease in mice to further investigate the contributions of
p75NTR on neurodegeneration and the promotion of Parkinson’s Disease.
Degeneration index calculations:
Parkinson’s Disease is known to promote neurodegeneration and thus
establishing a uniform method of calculating the degeneration present. This
method of calculation is a quantitative method of analysis to observe the
neuronal death in a strategic and objective manner. Because this assay
measures levels of degermation and is used to assigning numerical values to
conditions, it is important to remain objective and perform these calculations in a
manner that is not drastically different between experimental groups (Kasap et al
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2017). Neurite degeneration results from the introduction of dysfunction and
morphological changes resulting in an overall reduction of neurite integrity
(Kraemer et al 2022). To analyze and quantify neurite degeneration within a
particular cell population, the method of calculating a degeneration index (DI)
may be employed. The traditional method for quantifying neurodegeneration by
measuring the DI was performed by binarizing an image (obtained via
microscopy) and utilizing a software (usually ImageJ) to measure the pixel area
of the binarized image. The next step is to calculate the average area occupied
by neurite fragments. To perform a DI calculation, the area of neurite fragments
is divided by the overall neurite area. The resulting calculation is a measure of
neurite fragmentation. The DI value allows a researcher to analyze the impact of
the treatment on cell survival based upon the quantifiable death and
fragmentation of accompanying neurites (Sasaki et al 2009). Although proving to
be a useful tool of analysis, this traditional method of DI calculations is time
consuming and often resulted in low contrast images due to the software
limitations. By enhancing image contrast and incorporating optimized parameters
for the analysis, seen in setting a minimum particle size and pixel parameters for
detecting neurite fragmentations and an automated cell removal operation, the
time for performing the calculation is reduced while maintaining confidence in the
calculated degeneration index. Another method of traditional calculations of
neuronal degeneration utilizes a subjective quantification by analyzing specific
qualitative criteria in the sample, following this subjective scoring a program was
then utilized in sampling the axon and dendrite fields throughout the sample to
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compare values (Johnstone et al 2018). Traditional methods of DI calculation
involve a method of subjective scoring. Using subjectivity, a researcher was
blinded to the conditions of an image set and proceeded to score the images
based on a set value range of 0.0-1.0 with the scored values representing a
sample of fragmented neurite area (Kraemer et al 2022). This method of analysis
allows for a measure of neurite degeneration but is an assay that requires a
considerable time commitment and provides images with low levels of contrast.
Aims of developing optimized protocols:
The method of developing assays to investigate the contributions of
p75NTR signaling and to neurodegeneration that is often associated with
Parkinson’s Disease may be accomplished through a variety of experimental and
analytical designs. To investigate p75NTR signaling, three main aims are
investigated. Aim one is the optimization of an in vitro protocol of modeling
Parkinson’s Disease. This aim centers around utilizing the LUHMES cell culture
model exposed to different concentrations of the neurotoxic drugs 6-OHDA and
rotenone. After this exposure and subsequent time course, the levels of
neurodegeneration are evaluated by performing western blot analysis and
immunostaining to investigate the interaction between and induction of p75 NTR
proteolysis by its associated neurotrophins and co-receptors. This analysis
allowed for an investigation of what biological functions are observed with the
receptor. This form of investigation allowed for a greater understanding as to how
the p75NTR interacts in a model of Parkinson’s Disease. Aim two is the
optimization of in vivo protocols of modeling Parkinson’s Disease. To investigate
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aim two, a mouse model was utilized. To model Parkinson’s Disease, a
comparative study was established by using two genotypes of mice and
investigating the physiological and morphological differences between the
genotypes. The c57bl/6 (wildtype) mice were compared to the p75-/- (p75 Knock
Out) genotypes. These mice were utilized at ages between seven months and
two years to allow for appropriate natural development to occur. These studies
were also conducted in a manner of ensuring the subject of each experiment was
matched with an age-match pair, meaning the experiments took place to analyze
the effect of neurotoxic drugs on the brain of mice that were born within two
weeks of each other. To thoroughly investigate the contributions of p75NTR in the
mouse model of Parkinson’s Disease, assays and analysis were conducted to
collect qualitative and quantitative data. These data allow for multiple methods of
observing the effects of p75NTR on various regions of the brain in a simulation of
Parkinson’s Disease. Specific protocols for immunostaining were optimized and
developed, striatal section mean brightness of the TH stain was calculated, and
stereology was performed on the sections of substantia nigra to observe present
dopaminergic cells. The brightness of the TH stain is important to note as it is a
correlation to the amount of dopaminergic neurons present throughout the target
region where areas of less staining possess a reduced number of dopaminergic
neurons. Together, these methods of analysis provide a basis for if the
experimental methods were successful in promoting Parkinson’s Disease. Aim
three is centers around the development of a program to analyze the
degeneration index in a method that is less time consuming and provide high
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quality contrasting images of the experimental conditions. This aim was
investigated by comparing the original method of calculating a DI to an
automated method (ANDI) in order to compare the efficacy, time differences, and
subjectivity difference between the two methods. Using a free open-source
software FIJI (Fiji is just image J), a program was developed to automatically
assess a set of images. This automated method of calculating the DI allowed for
a more streamlined method of analyzing levels of neurite fragmentation. Previous
studies utilized a traditional method of calculating the DI which was a timeconsuming process that involved a multi-step approach to complete. Additionally,
issues in regard to optimizing the contrast of sample images were common in
using the traditional method of calculating DI (Fuller 2020). When substituting the
traditional method for the optimized method established by our lab, it was
experimentally observed to provide reliable data equivalent to the data collected
in the traditional method. However, when using the automated method, a more
streamlined approach was utilized and thus there was a reduction in time and
enhanced imagery contrast in investigating levels of DI (Kraemer et al 2022). The
automated method (ANDI) allowed for a more streamline The automated method
enhanced the overall efficiency of calculating the DI of a sample.
Materials and Methods:
LUHMES cell culture:
Lund Human Mesencephalic cells (LUHMES) are an immortalized cell line
of embryonic neuronal precursor cells. These cells are capable of proliferation
and growth, allowing the culture to undergo a set of treatment conditions.

21

LUHMES cells were plated on 60mm cell culture dishes coated with 200 µg/mL
poly-L-ornithine in sterile H2O (Sigma-Aldrich, St. Louis, MO) and 2µg/mL
fibronectin in sterile PBS (Sigma-Aldrich). Coating allows for an adhesion event
to occur between the surface of the plastic dishes and the cell bodies upon
plating. The medium of the cells was composed of Dulbecco’s Modified Eagle
Medium supplemented with Ham’s Nutrient Mixture F-12 (DMEM F12) (Gibco,
Waltham, MA), 1% (v/v) N2 supplement (Gibco), 2mM Glutamine (VWR, Radnor,
PA), and 40 ng/mL Basic Fibroblast Growth Factor (BFGF) (R&D Systems). The
media was incubated at 37°C for 20 minutes to allow for proper establishment of
5% CO2 levels. After plating, the cells were left in the incubator for five days,
every two days (or when deemed necessary due to general health and
confluence) a ½ media change was performed. After growing to approximately
60% confluency (or reaching day five), the cells were transferred into a coated
dish with a differentiation medium. The differentiation medium allowed for cells to
develop into the neuronal precursor cells. Differentiation medium was comprised
of DMEM F12 (Gibco) was supplemented with 1mM db cAMP (Enzo Life
Sciences), 2mM Glutamine (VWR), 1% (v/v) N2 (Gibco), 2ng/mL GDNF (R&D
Systems), and 1 µg/mL Tetracycline (Sigma-Aldrich). Unlike the growth media,
BFGF was not included in the media, this was done to prevent any additional cell
growth. The media was then warmed in the incubator at 37°C for 20 minutes to
reach appropriate levels of CO2.
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Cell Treatments
On the fifth day of differentiation, the cultures were subjected to treatment.
These treatments were performed to observe the effect of various concentrations
of chemicals on the cells. The information from these treatments allowed for
analysis of whether the chemicals induced p75NTR proteolysis. Treatments were
conducted with 6-hydroxydopamine (6-OHDA) (Sigma-Aldrich) and rotenone
(Sigma-Aldrich) to investigate the effect of these chemicals on intracellular
interactions within an in vitro model of Parkinson’s Disease. Because of their
reactivity and sensitivity, both 6-OHDA and rotenone were stored under inert
(nitrogen) gas in amber epi tubes (to protect from light) at -80°C until required for
usage. The 6-OHDA was prepared in a solvent of dimethyl sulfoxide (DMSO) at a
stock concentration of 10mM. The rotenone was prepared in a solvent of DMSO
at a stock concentration of 100mM. Cell treatments were conducted at various
concentrations of each chemical including doses of 1 µM, 2.5 µM, 5 µM, 7.5 µM,
and 10 µM concentrations. Each treatment set consisted of one vehicle (addition
of the solvent DMSO) to allow for comparisons between treatment groups and a
normal cell group. The treatment was applied and allowed to interact with the cell
culture for 18 hours before lysis was performed.
Lysate Preparation:
After the 18-hour treatment course, the cells were lysed and analyzed via
western blot analysis. Lysates were prepared by allowing the cells to rest on ice
and removing the media. Approximately 2mL of PBS was added to the dish and
the cells were scraped in a clockwise motion and collected into a 15mL conical
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tube. The dish was rinsed with 3mL of PBS and scraped in a counterclockwise
motion and once again, the solution was added to the 15mL conical tube. This
process was performed with each dish of the treatment. The conical tubes were
then centrifuged at 2000G for five minutes at 4°C. After centrifugation, a lysis
buffer of Nonidet P-40 (NP40) (Sigma Aldrich) (comprised of a protease inhibitor
and a PhosStop phosphatase inhibitor tablet) was added and the solution was
triturated to break open the pellet of cells. The NP40 buffer served as a non-ionic
and non-denaturing detergent. The lysates were then stored in -80°C until
required for further analysis.
Western blot analysis:
Western blot analysis was performed to investigate the proteolysis of
p75NTR when the receptor was exposed to a chemical known to promote oxidative
stress within cellular populations. This analysis was performed to investigate the
roles of co-receptors (TrkB and sortilin) and to analyze the extent of p75NTR
fragmentation caused by 6-OHDA and rotenone. The lysates were sonicated and
clarified. A Bradford assay was performed to obtain the necessary amount of
each lysate to add to ensure proper protein concentrations were achieved. This
assay was performed by creating a Bradford curve and calculated R2 value. A
concentration was created from using 5X Bradford assay solution (Bio Rad) and
Bovine Serum Albumin (BSA) protein concentration standards (GibCo). After
generating a Bradford curve with an R 2 greater than 0.97, a microliter of lysate
solution was added to the gradient and the assay was once again run. After
running the curve, a calculation (slope equation) was constructed to figure the
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amount of protein to add to achieve the desired concentration levels. Additionally,
the amount of 6X and 1X buffer to load was also calculated to ensure the
aforementioned concentration levels were achieved. The lysates were prepared
by adding a Laemmle buffer (Bio Rad) to the lysates and then boiling them for
eight minutes and then being added to a gel composed of 1.5M Tris, 30%
Acrylamide, SDS, APS, and TMED. The samples were separated by
electrophoresis and transferred to a polyvinylidene fluoride (PVDF) membrane.
The gel membrane containing the lysate samples was blocked in a solution of
5% milk in 0.1% Tween in PBS. After blocking, the primary antibody was
introduced to the blot. The primary antibody used was a specific to detecting the
intracellular domain of p75NTR and was utilized at a concentration of 1:3000 (in
milk) overnight at a temperature of -20°C. The next step utilized an anti-rabbit
secondary antibody at a concentration of 1:12000 for an hour and a half at room
temperature. After the incubation period, the p75NTR fragmented bands were
visualized using enhanced chemiluminescence (ECL) and a ChemiDoc imaging
station. After visualization, the blots were stripped and visualized with MAB1501
at a 1:1000 concentration overnight at -20°C. The next step utilized a horseradish
peroxidase conjugated anti-mouse secondary antibody at a 1:5000 concentration
for an hour and a half a room temperature. The actin band was then imaged
using ECL or West Fempto substrate and an analysis program on the ChemiDoc
imaging station.
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In vivo surgery mouse model:
To investigate the effect of p75NTR expression on dopaminergic neurons
within a mouse model of Parkinson’s Disease, an in vivo surgical procedure was
designed. This expression was investigated by exposing the dopaminergic
neurons to chemicals intended to induce oxidative stress. Upon the promotion of
oxidative stress, the physiological and morphological traits were investigated.
Comparisons were drawn between a line of C75bl/6 (WT) and p75 NTR -/- (P75 ko)
mice. To obtain comparable data, studies were conducted on mice that were age
matched and were between the ages of seven months and a year and a half. To
perform a surgery using 6-OHDA, the mouse was given an intraperitoneal (IP)
injection with 2 mg/mL desipramine in PBS (at 10mg/kg concentration) and
allowed to sit for 30 minutes. Desipramine is a chemical known to inhibit the
transmittance of norepinephrine and thus serves to protect the noradrenergic
terminals by blocking the uptake of 6-OHDA into these terminals (Kraemer 2022).
During the period of rest, the 6-OHDA was prepared at 2mg/mL using 0.02%
PBS ascorbate. The 6-OHDA was diffused at a rate of 0.1 µL/minute.
Although 6-OHDA and rotenone are two neurotoxic chemicals assumed to
induce Parkinson’s Disease, the methods of doing so differ. Due to the nature of
rotenone, a desipramine injection was not needed. Instead, the rotenone was
prepared at 2.51 µL/96.5 µL in a solvent of DMSO and the surgical procedure
proceeded in a manner identical to that of the 6-OHDA surgery (after the
desipramine injection). Both the 6-OHDA and rotenone surgeries were conducted
in the same manner after the preparation of the chemical. The next step in the
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surgery protocol was to secure the mouse to a stereotaxic rig via a nose cone
and ear bars. A subcutaneous injection of Meloxicam was administered at 1
mg/mL by body weight for a final concentration of 5mg/kg. Meloxicam serves to
release analgesics in mice and thus serves as a method of pain and infection
prevention/management after a surgery has been conducted. A Hamilton syringe
was primed with isopropyl alcohol and then rinsed with the solvent before being
loaded with the neurotoxic chemical. To ensure a sterile environment, the fur of
the mouse was trimmed, and the skin of the mouse was disinfected with 70%
ethanol and povidone iodine. A scalpel was utilized to create a vertical midline
incision and hydrogen peroxide was utilized to clean the exposed bone plate.
The stereotaxic rig was utilized to navigate the tip of the syringe to Bregma. From
Bregma, specific coordinates were applied where the anterior-posterior value
was set to +0.5mm, the medial-lateral was set to -1.9mm, and the dorsal-ventral
was set to +3.5mm. At this location, a small hole was drilled into the skull using a
dental drill and the syringe was lowered into the hole. The neurotoxin was
administered and after being expelled, the syringe was allowed to sit in the brain
for an additional five minutes to prevent capillary action from drawing up the
chemical. The mouse was sutured and 200 µL of PBS was administered to
replace fluid levels. The mouse was monitored for symptoms and health of the
wound site for a time course of 4, 8, and 12 hours after the surgery. Additionally,
Meloxicam was administered 24 and 48 hours after the surgery to prevent
infection and pain.
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Immunostaining striatum:
The tissue was permeabilized with 0.3% Triton-X-100 in sterile 1X PBS.
The tissue was blocked with 10% normal goat serum (NGS) in PBS for an hour.
The blocking solution was removed and a fresh solution of 10% NGS in PBS was
made, and the primary antibody Anti-Tyrosine hydroxylase (AB152) was added in
a 1:400 concentration. The solution was applied to the tissue and incubated
overnight at 4°C in a humidity chamber. The next day, washes were performed
on the tissue and a secondary Alexa fluorophore secondary antibody (Alexa fluor
488) was applied at a concentration of 1:500 in PBS for an hour and a half at
room temperature (and protected from light to abnormal excitation of the
fluorophore). To stain the nuclei, 4’,6-diamidino-2-phenylindole (DAPI) was
added at a concentration of 1:200 and allowed to incubate for five minutes at
room temperature. The slides were washed, mounted with fluoromount-G
(Southern Biotech), and allowed to dry.
Immunostaining substantia nigra:
The tissue was permeabilized with 0.1% Triton-X-100 in sterile 1X PBS.
The tissue was incubated in the Vector-elite staining kit blocking serum diluted
with sterile PBS for 30 minutes at room temperature. The tissue was then
incubated in fresh blocking serum and PBS containing primary antibody (AB152)
at a concentration of 1:400 at 4°C overnight. After performing washes, the tissue
was incubated for 30 minutes in biotinylated secondary antibiotic serum. The
ABC reagent provided by the kit was incubated for 30 minutes. A 3,3’diaminobenzidine (DAB substrate) was incubated for eight minutes to develop in

28

intensity. The slide was mounted with fluoromount-G (Southern Biotech) and was
allowed to dry.
Image capture:
To investigate the levels of tyrosine hydroxylase staining (TH) and
dopaminergic innervation of the striatum, striatum image capture was conducted
using a Zeiss LSM 800 confocal microscope. The striatum was imaged using
ZEN software and the images were quantified for mean brightness through FIJI
(an open-sourced deviation of ImageJ). The images were analyzed in regard to
the mean brightness and quantified to obtain analysis of the dopaminergic
neurons within the sample of the striatum. Because the samples were collected,
immunostained, and imaged as an age match pair, the results of the
quantification are comparable. The average intensity of immunostaining was
analyzed to investigate the average TH brightness within samples resulting in a
comparative investigation into striatal innervation in the presence of p75NTR.
Stereology:
To investigate levels of tyrosine hydroxylase staining (TH) and presence
of dopaminergic cells within the substantia nigra, the tissue of this region was
immunostained and analyzed. The tissue was immunostained to target the TH
present in the population of dopaminergic neurons in the region. This
immunostaining was then quantified by using a stereology program and Zeiss
program through confocal microscopy. Parameters including sample size,
sample thickness, and frame size were input into the program. As the program
focused through the z-axis, the program allowed the selection of dopaminergic
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cells; these cells served as a representative sample of dopaminergic neurons
from each tissue sample.
Optimized macro analysis (ANDI) and degeneration index calculation:
To optimize a macro analysis and perform optimized degeneration index
calculations, sympathetic neurons were cultured, immunostained, and imaged
with both standard and confocal microscopy. Eight-well chamber slides for this
experiment were coated with 100 µg/mL poly-L-ornithine (Sigma-Aldrich), 1 µg
/mL Fibronectin (Sigma-Aldrich),100 ng/mL poly-D-Lysine (Sigma-Aldrich), and
10 µg/mL Laminin (Corning, Corning, NY). The sympathetic ganglia from mice
pups (>7 days old) were collected and plated in growth media. The growth media
was composed of DMEM (Gibco), 10% fetal bovine serum (Invitrogen), 2mM
Glutamine (Corning), and 40 ng/mL of NGF (Fisher Scientific). A concentration of
5 µM Ara-C (Sigma-Aldrich) was utilized to aid in the removal of non-neuronal
cells such as Schwann cells from the culture. The slides of cells were
immunostained to investigate levels of βIII-tubulin and TH. In addition to these
immunofluorescent labels, a DAPI counterstain was applied to label the nuclei of
the cells. After fixing, the cells were permeabilized with 0.3% Triton-X-100. The
cells were blocked with 10% NGS in sterile 1X PBS for one hour. The primary
antibody (AB152) was added to fresh blocking solution so that the concentration
was at a 1:400 concentration at 4°C overnight. The slides were washed and
incubated with Alexa fluorophore 568 as the secondary antibody at a
concentration of 1:500. DAPI in PBS was added for 5 minutes. The slides were
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washed with sterile 1X PBS and were mounted using fluoromount-G (Sourthern
biotech).
The treatment, immunostaining, and image capture took place in eightwell chambered slides with each chamber subjected to a specific treatment
condition. Analysis was first performed via a Nikon Eclipse II Ti-U Inverted
Microscope System employed with a NIS Element Acquisition Software. To
optimize the microscope optics, Kohler illumination was performed prior to the
image capture section. Cells were imaged under phase contrast microscopy and
fluorescent microscopy images were collected on a TUJ1 and TH channel. For
the phase contrast images, the microscope was set to 20x magnification with a
1.00x gain and 21 second exposure time. If needed, the gain and exposure time
was adjusted so that the brightness of the picture was consistent. Each of the
adjustment made in regard to gain and exposure time was noted and kept
constant through the image set. A background image was taken to correct for
any camera imperfections. Background correction was employed with each
phase contrast imaging set. The well was imaged in five different representative
spots where the neurites were defined and where cells were evenly distributed.
Phase contrast, TUJ1, TH, and DAPI images were collected from each chamber.
To further the analysis, the wells were also imaged on the confocal at 0x
magnification. Using Nis Element Acquisition software in tandem with Nikon
inverted microscope (standard microscopy), an image was collected from each
channel. Each of the images was categorized as phase contrast, fluorescent, and
DAPI folders and ensured that each set matched up. To calculate the
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degenerative index (DI) measurements cited in traditional methods, each image
was input into FIJI (open-source ImageJ software). The images were binarized
so that the background was white contrasted with the black cells of the
foreground. The freehand tool was utilized to trace over cell bodies to convert the
mass into the white background. The measure tool was utilized to receive a
measurement of the total area occupied by the black background. Neurite
fragmentation was measured using parameters in the FIJI analysis. In an
analysis of the traditional method of calculating DI, this fragmentation was
analyzed by measuring size of fragments between 20-10,000 pixels and with
circulatory settings at 0.20-1.00. In an analysis of the optimized automated
method of analyzing neurite fragmentation, the analyze particle tool within the
FIJI software was utilized with parameters of 0-9 pixels and circulatory
parameters of 0.0-1.0. The subsequent calculation to determine the DI was
obtained by summing the neurite fragments divided by the total area occupied by
the background to provide the DI of the image.
Results:
In vitro results:
LUHMES cells were cultured, differentiated, and treated with 6-OHDA or
rotenone to investigate various interactions of p75NTR including the proteolysis,
interaction of co-receptors, neurotrophin interaction, and response to oxidative
stress. The treatment conditions of rotenone were investigated to observe the
effect of the chemical on the proteolysis of p75NTR as a model of Parkinson’s
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Disease. The event of p75NTR proteolysis is a two-step process (Figure 1A). The
experiments (Figure 1C) revealed a dose dependent increase of degeneration
and death in the population of LUHMES cells. The lysates procured from the
treatments were analyzed through western blot analysis to further investigate the
proteolysis and accumulation of p75NTR fragments induced following rotenone
application (Figure 1B). We assumed the application of rotenone to a population
of cells would mimic oxidative stress and promote the proteolysis of p75NTR. This
was then investigated when a population of LUHEMS cells (thought to possess
dopaminergic characteristics by expressing the p75NTR receptor) was exposed to
rotenone and analyzed for the proteolysis of the receptor. We observed the
p75NTR ICD fragment to be present in 1µm and 10µm rotenone conditions. The
co-receptor TrkB was not present within the lysates of LUHMES or HEK cell
culture but was expressed in the lysates of the whole brain (Figure 2A). The coreceptor sortilin was found to be present in vehicle, rotenone, and 6-OHDA
treatment conditions (Figure 2B). Sortilin was investigated in a population of
LUHMES cells and was found to be present in an immunostaining assay (Figure
2C). TrkB was not present in LUHMES cells while sortilin was found to be
present in LUHMES cells after treatment and analysis via western blot analysis.
In vivo results:
To optimize a mouse model of Parkinson’s Disease, stereotaxic surgeries
were performed with 6-OHDA and rotenone. Using age matched mice of two
distinct genotypes (one lacking the p75NTR gene and one exhibiting the p75NTR
gene), comparative studies were conducted to determine the physiological and
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morphological divergences and effects in regard to p75NTR on neuronal protection
and degeneration. It was experimentally observed that an injection of 2µg/mL of
10mM 6-OHDA in 0.02% PBS ascorbate at a rate of 0.1µl/minute resulted in
substantial loss of dopaminergic neurons from regions contralateral and
ipsilateral of the injection within both the striatum (Figure 3A) and the substantia
nigra (Figure 3B). Similarly, rotenone (in a DMSO solvent) was administered at a
rate of 0.1µl/minute resulting in loss of dopaminergic cells from the striatum and
substantia nigra. In these studies, there was an observable loss of dopaminergic
neurons between the ipsilateral and contralateral regions of the injection site for
both 6-OHDA and rotenone within the region of the striatum (Figure 3C) (Figure
3D).
Optimized degeneration index results:
Traditional methods of degeneration index (DI) calculations presented
with issues in efficiency and image contrast. ANDI was established by optimizing
a protocol of DI calculation by adjusting the parameters of the study to quantify
neurite degeneration. Image sets of phase contrast, TUJ1, TH, and DAPI were
obtained through standard and confocal microscopy. These image sets were
done with vehicle wells and with various treatment conditions of hydrogen
peroxide (Figure 4A) (Figure 4B). The automated method proved to be an
effective method of quantifying neurite degeneration as there was no statistical
significance detected between traditional and optimized methods. Although there
was not a statistical difference in results, there was a greater efficiency
associated with the automated ANDI model in regard to time as well as the ability
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to provide a higher contrasting image through the program. This ANDI program
utilized particle-remover plugins to automatically remove non-neurite and debris
fragments from the images. Measurement and calculation of the DI was obtained
by dividing neurite fragment area by total neurite area. A treatment group utilized
hydrogen peroxide to establish the automated macro successfully measures the
neurite degeneration in sources besides 6-OHDA (Figure 4C) (Figure 4D). The
use of SCG cultures to collect primary neurons allows for the exploration of ANDI
and measurement of a population other than LUHMES. Upon comparing the
calculated DI from studies conducted through the traditional manual method and
the optimized ANDI method, there was no statistical difference between the
calculation values. The ANDI method was established as a more efficient method
of DI calculations as the results were statistically insignificant in comparison to
the manual method while the time required to perform the optimized method was
reduced in comparison to performing the manual method (Figure 4E) (Figure 4F).
Discussion:
Investigation of the transmembrane protein p75NTR may result in
understanding the relationship between its activation and neurodegeneration in
regard to the development of Parkinson’s Disease. It has been observed that
p75NTR is present in many models of neuronal degeneration and thus may be
capable of mediating neurodegenerative diseases (Gitler et al 2017). To further
investigate the signaling mechanisms and relationships of p75NTR, we optimized
multiple protocols for investigating the effects of p75NTR expression on
dopaminergic neuron degeneration, analyzing the mechanisms of p75NTR upon
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exposure to oxidative stress, and establishing an efficient method of calculating
the DI. While the specific signaling mechanisms of p75NTR remain unknown,
optimizing in vivo and in vitro methods of modeling Parkinson’s Disease will allow
for us to understand the contributions of the receptor to the disease. 6-OHDA is
known to induce oxidative stress allowing for a method of modeling Parkinson’s
Disease. Rotenone is a chemical known to promote the formation of Lewy Bodies
and oxidative stress is induced allowing for the chemical to be used to model
Parkinson’s Disease. In establishing an optimized method of calculating the DI, a
more efficient method of analyzing the fragmentation and degeneration in the
sample. The optimized calculations which have been shown to produce similar
values seen in a manual method of calculating the DI. It was not statistically
significant between the values from ANDI or manual; thus, the method of ANDI is
a more time efficient method of analysis without skewing objectivity of analysis.
The experimental design included in vitro and in vivo methods. Performing
a variety of assays allows for an in-depth analysis of p75NTR under various
conditions including interactions between co-receptors, neurotrophins, and
oxidative stress. Through past western blot analyses, it was discovered that
P75NTR undergoes a proteolytic event when exposed to an outside stimulus such
as oxidative stress. To further analyze the signaling cascade of p75NTR, 6-OHDA
and rotenone were utilized as cell treatments and in an in vivo surgical procedure
to induce Parkinson’s Disease in a mouse model. From these treatments,
western blot analysis enables measurement of fragmentation upon proteolysis of
the receptor. It was expected that rotenone would cause neurodegeneration;
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however, the method through which p75NTR experiences proteolysis and
subsequent signaling cascade has not been well documented or understood.
The use of in vivo studies are necessary to investigate the role of p75NTR
in mice models to further investigate the effect of p75NTR within a biological
system. These studies were performed with two chemicals known to induce
oxidative stress. Preliminary data suggests that p75NTR may play a role in
neuronal protection in Parkinson’s Disease. Both 6-OHDA and rotenone were
demonstrated to model Parkinson’s Disease by promoting neurodegeneration
and a general reduction of dopaminergic neurons.
In vitro studies have demonstrated that the LUHMES cells are a model for
dopaminergic neurons (Tushaus et al 2021). By utilizing a population of cells that
exhibit similar characteristics commonly observed in dopaminergic neurons.
These LUHMES cells are able to proliferate and differentiate into postmitotic
neuronal cells upon introduction to growth media or differentiation media
(Harischandra et al 2020). In utilizing cultures of LUHMES cells, we were able to
investigate the relationship between p75NTR and other biological ligands and coreceptors. We found that the co-receptor TrkB is not expressed in dopaminergic
cells from the ventral midbrain, but the co-receptor sortilin is. This is interesting
as sortilin is a type-1 receptor that is thought to promote apoptotic pathways
(Nykajaer and Willnow 2012). The presence of sortilin may form an interaction
with p75NTR resulting in apoptosis induction and subsequent neurodegeneration.
An automated neurite degeneration index (ANDI) was created to aid in
optimizing an efficient protocol to calculate the degeneration index.
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Traditional/manual methods of calculating the degeneration index are time
consuming and provide low contrast images. In optimizing the protocol using FIJI
and a macro program, we were able to provide efficiency and a greater quality
than what was previously able to be achieved. ANDI was shown to provide
accurate DI calculations for treatment groups of hydrogen peroxide at various
concentration thus allowing a confirmation that ANDI is an optimized method of
DI calculations for various cell and treatment types. In regard to statistical
accuracy, there was no statistical significance found between the DI calculated
through a manual method and through ANDI. This resulted in an indication that
ANDI is an optimized protocol for measuring DI calculation as it aids in the
overall efficiency and speed of the calculations while also provides a better set of
contrast images by adjusting the parameters in FIJI. By adjusting the particle
remover tool, pixel function, and circulatory functions, the images were produced
with sharper contrast.
Currently, there needs to be further investigation in regard to how p75NTR
impacts neurodegeneration and how these models are translational to
Parkinson’s Disease in the human population. Further studies from our lab may
provide an analysis for neuronal and axonal degeneration in response to
oxidative stress. Completion of these additional studies will lead to novel insight
into the impact of specific p75NTR signaling mechanism on neurodegeneration
associated with Parkinson’s Disease.
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